|
1
|
Bergeron S, Lemieux E, Durand V, Cagnol S,
Carrier JC, Lussier JG, Boucher MJ and Rivard N: The serine
protease inhibitor serpinE2 is a novel target of ERK signaling
involved in human colorectal tumorigenesis. Mol Cancer. 9:2712010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang K, Wang B, Xing AY, Xu KS, Li GX and
Yu ZH: Prognostic significance of SERPINE2 in gastric cancer and
its biological function in SGC7901 cells. J Cancer Res Clin Oncol.
141:805–812. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zheng D, Gui B, Gray KP, Tinay I, Rafiei
S, Huang Q, Sweeney CJ, Kibel AS and Jia L: Secretory leukocyte
protease inhibitor is a survival and proliferation factor for
castration-resistant prostate cancer. Oncogene. 35:4807–4815. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stępień T, Brożyna M, Kuzdak K, Motylewska
E, Komorowski J, Stępień H and Ławnicka H: Elevated concentrations
of SERPINE2/protease nexin-1 and secretory leukocyte protease
inhibitor in the serum of patients with papillary thyroid cancer.
Dis Markers. 2017:49621372017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Monard D: SERPINE2/Protease Nexin-1 in
vivo multiple functions: Does the puzzle make sense? Semin Cell Dev
Biol. 62:160–169. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nukiwa T, Suzuki T, Fukuhara T and Kikuchi
T: Secretory leukocyte peptidase inhibitor and lung cancer. Cancer
Sci. 99:849–855. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Valiente M, Obenauf AC, Jin X, Chen Q,
Zhang XH, Lee DJ, Chaft JE, Kris MG, Huse JT, Brogi E and Massagué
J: Serpins promote cancer cell survival and vascular co-option in
brain metastasis. Cell. 156:1002–1016. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wagenblast E, Soto M, Gutiérrez-Ángel S,
Hartl CA, Gable AL, Maceli AR, Erard N, Williams AM, Kim SY,
Dickopf S, et al: A model of breast cancer heterogeneity reveals
vascular mimicry as a driver of metastasis. Nature. 520:358–362.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Konturek A, Barczyński M, Cichoń S,
Pituch-Noworolska A, Jonkisz J and Cichoń W: Significance of
vascular endothelial growth factor and epidermal growth factor in
development of papillary thyroid cancer. Langenbecks Arch Surg.
390:216–221. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xue L, Su D, Li D, Gao W, Yuan R and Pang
W: MiR-200 regulates epithelial-mesenchymal transition in
anaplastic thyroid cancer via EGF/EGFR signaling. Cell Biochem
Biophys. 72:185–190. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang T, Zhu Q, Li X, Zhu G, Deng S, Wang
Y, Ni L, Chen X, Zhang Y, Xia T, et al: Correction: Protease Nexin
I is a feedback regulator of EGF/PKC/MAPK/EGR1 signaling in breast
cancer cells metastasis and stemness. Cell Death Dis. 11:132020.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Z, Liu ZB, Ren WM, Ye XG and Zhang
YY: The miR-200 family regulates the epithelial-mesenchymal
transition induced by EGF/EGFR in anaplastic thyroid cancer cells.
Int J Mol Med. 30:856–862. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu J, Zhang X, Wang H, Ge S, Gao T, Song
L, Wang X, Li H, Qin Y and Zhang Z: HCRP1 downregulation promotes
hepatocellular carcinoma cell migration and invasion through the
induction of EGFR activation and epithelial-mesenchymal transition.
Biomed Pharmacother. 88:421–429. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-DDct method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang D, Zheng X and Li M: Correlation
analysis between the pre-operative contrast-enhanced ultrasound
parameters and biological characteristics of papillary thyroid
carcinoma and associated risk factors for prognosis after
radiofrequency ablation. Exp Ther Med. 20:1575–1581. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gupta S, Patel A, Folstad A, Fenton C,
Dinauer CA, Tuttle RM, Conran R and Francis GL: Infiltration of
differentiated thyroid carcinoma by proliferating lymphocytes is
associated with improved disease-free survival for children and
young adults. J Clin Endocrinol Metab. 86:1346–1354. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Barabadze E, Munjishvili V and Burkadze G:
Braf antibody expression in different types of thyroid nodular
lesions. Georgian Med News. 271:107–113. 2017.
|
|
18
|
Tang T, Zhu Q, Li X, Zhu G, Deng S, Wang
Y, Ni L, Chen X, Zhang Y, Xia T, et al: Protease Nexin I is a
feedback regulator of EGF/PKC/MAPK/EGR1 signaling in breast cancer
cells metastasis and stemness. Cell Death Dis. 10:6492019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
D'Anneo A, Carlisi D, Emanuele S, Buttitta
G, Di Fiore R, Vento R, Tesoriere G and Lauricella M: Parthenolide
induces superoxide anion production by stimulating EGF receptor in
MDA-MB-231 breast cancer cells. Int J Oncol. 43:1895–1900. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Su X, Shen Z, Yang Q, Sui F, Pu J, Ma J,
Ma S, Yao D, Ji M and Hou P: Vitamin C kills thyroid cancer cells
through ROS-dependent inhibition of MAPK/ERK and PI3K/AKT pathways
via distinct mechanisms. Theranostics. 9:4461–4473. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen Y, Wang X, Xu J and Lu L: SerpinE2, a
poor biomarker of endometrial cancer, promotes the proliferation
and mobility of EC cells. Cancer Biomark. 19:271–278. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Akaishi J, Kondo T, Sugino K, Ogimi Y,
Masaki C, Hames KY, Yabuta T, Tomoda C, Suzuki A, Matsuzu K, et al:
Prognostic impact of the turin criteria in poorly differentiated
thyroid carcinoma. World J Surg. 43:2235–2244. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Su JJ, Hui LZ, Xi CJ and Su GQ:
Correlation analysis of ultrasonic characteristics, pathological
type, and molecular markers of thyroid nodules. Genet Mol Res.
14:9–20. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Williamson T, Mendes TB, Joe N, Cerutti JM
and Riggins GJ: Mebendazole inhibits tumor growth and prevents lung
metastasis in models of advanced thyroid cancer. Endocr Relat
Cancer. 27:123–136. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bravo R, Frank R, Blundell PA and
Macdonald-Bravo H: Cyclin/PCNA is the auxiliary protein of DNA
polymerase-delta. Nature. 326:515–517. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim JY, Kim KH, Lee WR, An HJ, Lee SJ, Han
SM, Lee KG, Park YY, Kim KS, Lee YS and Park KK: Apamin inhibits
PDGF-BB-induced vascular smooth muscle cell proliferation and
migration through suppressions of activated Akt and Erk signaling
pathway. Vascul Pharmacol. 70:8–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sajeevan TP, Saraswathi TR, Ranganathan K,
Joshua E and Rao UD: Immunohistochemical study of p53 and
proliferating cell nuclear antigen expression in odontogenic
keratocyst and periapical cyst. J Pharm Bioallied Sci. 6 (Suppl
1):S52–S57. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang D, Yao X, Zhou J, Zhou H, Lu G and
Wang Y: Correlations of PCNA expression with thyroid cancer
ultrasound and histopathologic features. Int J Clin Exp Pathol.
12:1378–1384. 2019.PubMed/NCBI
|
|
29
|
Cornianu M, Stan V, Lazăr E, Dema A, Golu
I, Tăban S, Vlad M, Faur A, Vărcuş F and Babău F: Evaluation of
proliferation potential in thyroid normo-/hypofunctioning and
hyperfunctioning nodules. Rom J Morphol Embryol. 52:545–553.
2011.PubMed/NCBI
|
|
30
|
Pagliara V, Adornetto A, Mammì M, Masullo
M, Sarnataro D, Pietropaolo C and Arcone R: Protease Nexin-1
affects the migration and invasion of C6 glioma cells through the
regulation of urokinase plasminogen activator and matrix
metalloproteinase-9/2. Biochim Biophys Acta. 1843:2631–2644. 2014.
View Article : Google Scholar : PubMed/NCBI
|
